THE EFFECTS OF CO-DERGOCRINE ON CYCLOSPORINE A PHARMACOKINETICS AND PHARMACODYNAMICS

被引：3

作者：

HEINRICHS, DA

MARTELL, R

STILLER, CR

FREEMAN, D

CARRUTHERS, G

机构：

[1] UNIV WESTERN ONTARIO HOSP, CTR TRANSPLANT STUDIES, LONDON N6A 5A5, ONTARIO, CANADA

[2] UNIV WESTERN ONTARIO HOSP, DIV CLIN PHARMACOL, LONDON N6A 5A5, ONTARIO, CANADA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 24卷 / 01期

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03148.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：117 / 118

页数：2

相关论文

共 9 条

[1] CARRUTHERS SG, 1983, CLIN CHEM, V29, P180
[2] Donatsch P, 1981, J Immunoassay, V2, P19, DOI 10.1080/01971528108062989
[3] MIHATSCH MJ, 1983, TRANSPLANT P, V15, P2821
[4] ROSE NR, 1980, MANUAL CLIN IMMUNOLO
[5] PROLACTIN RECEPTORS ON HUMAN-LYMPHOCYTES AND THEIR MODULATION BY CYCLOSPORINE
RUSSELL, DH
MATRISIAN, L
KIBLER, R
LARSON, DF
POULOS, B
MAGUN, BE
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 121 (03) : 899 - 906
[6] RYFFEL B, 1983, ARCH TOXICOL, V53, P107
[7] SCHINDLER R, 1985, CYCLOSPORIN AUTOIMMU
[8] SEIGL H, 1983, TRANSPL P, V15, P2719
[9] SEIGL H, 1984, PREVENTION SANDIMMUN